Midostaurin Approved by FDA for Acute Myeloid Leukemia

The FDA has approved midostaurin for patients with newly diagnosed acute myeloid leukemia (AML) with mutations in the FLT3 gene. The approval also several other conditions.

from Cancer via ola Kala on Inoreader http://ift.tt/2qFx0zO
via IFTTT